Neurocritical Care

, Volume 16, Issue 1, pp 29–34 | Cite as

The Neurocritical Care Research Network: NCRN

  • J. I. Suarez
  • R. Geocadin
  • C. Hall
  • P. D. Le Roux
  • S. Smirnakis
  • C. A. C. Wijman
  • O. O. Zaidat


Neurocritical care diseases carry a high morbidity and mortality. Therapeutic and technological advances in neurocritical care have greatly improved the outcome of a variety of life-threatening disorders including traumatic brain injury, acute ischemic stroke, intracerebral and subarachnoid hemorrhage, and anoxic injury following cardiac arrest. These advances have stemmed from a better understanding of the physiology of neurocritical care illnesses, improved neuromonitoring techniques, and the introduction of more efficacious treatments. Despite all the advances in neuromonitoring, diagnostic imaging, and emerging treatments, much research needs to be undertaken in neurocritical care. Many of the clinical trials carried out in the general critical care population have excluded neurocritical care patients. For instance, the landmark ARDSNET trial that demonstrated the beneficial effects of low tidal volume ventilation in patients with ARDS cannot be directly applied to neurocritical care patients who frequently may experience this pulmonary complication. There is a need for a more cohesive and integrated research system or network to establish a track record for high-quality, investigator-initiated clinical research in neurocritical care. Such a system may help us overcome potential impediments to the future advancement of neurocritical care research. We propose the creation of the neurocritical care research network. The mission of the Network is to facilitate multicenter and multidisciplinary collaboration and patient enrollment in clinical trials of specific neurocritical care diseases.


Neurocritical care Critical care Clinical trials Research network Consortium 


  1. 1.
    Smith M. Neurocritical care; has it come of age? B J Anaesthesia. 2004;93:753–5.CrossRefGoogle Scholar
  2. 2.
    Bleck T. Critical care and emergency neurology. In: Cohen MM, editor. The American academy of neurology: The first 50 years 1948–1998. St Paul: American Academy of Neurology; 1998. pp. 225–7.Google Scholar
  3. 3. Accessed 1 June 2010.
  4. 4.
    Mayer SA, Coplin WM, Chang C, et al. Program requirements for fellowship training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:166–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Mayer SA, Coplin WM, Chang C, et al. Core curriculum and competencies for advanced training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:159–65.PubMedCrossRefGoogle Scholar
  6. 6. Accessed 1 June 2010.
  7. 7. Accessed 1 June 2010.
  8. 8. Accessed 1 June 2010.
  9. 9.
    The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.CrossRefGoogle Scholar
  10. 10.
    The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.CrossRefGoogle Scholar
  11. 11.
    The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–84.CrossRefGoogle Scholar
  12. 12.
    Cook DJ, Guyatt GH, Marshall J, et al., for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–7.Google Scholar
  13. 13.
    Sandham JD, Hull RD, Brant RF, et al., for the Canadian Critical Care Trials Group. A randomised controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients N Engl J Med. 2003;38:5–14.Google Scholar
  14. 14.
    Cook DJ, Rocker G, Marshall J, et al., for the Level of Care Study Investigators and the Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.Google Scholar
  15. 15.
    Hutchison SJ, Ward RE, Lacroix J, et al., for the Hypothermia Pediatric Head Injury Trial investigators and the Canadian Critical Care Trials Group. Hypothermia Therapy Following Traumatic Brain Injury in Children. N Engl J Med. 2008;358:2447–56.Google Scholar
  16. 16.
    Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–43.PubMedCrossRefGoogle Scholar
  17. 17.
    The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.CrossRefGoogle Scholar
  18. 18.
    The MERIT Study Investigators. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet. 2005;365:2091–7.CrossRefGoogle Scholar
  19. 19.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.CrossRefGoogle Scholar
  20. 20.
    Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:557–63.CrossRefGoogle Scholar
  21. 21.
    Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–63.PubMedCrossRefGoogle Scholar
  22. 22.
    Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–24.PubMedCrossRefGoogle Scholar
  23. 23.
    Pickard JD, Murray GD, Illingwoth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.PubMedCrossRefGoogle Scholar
  25. 25.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedGoogle Scholar
  26. 26.
    Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.PubMedCrossRefGoogle Scholar
  27. 27.
  28. 28.
    Wright WL. Mapping neurocritical care units. Curr Neurocritical Care Soc Newslett. 2007;2(3):4.Google Scholar
  29. 29.
  30. 30.
  31. 31.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • J. I. Suarez
    • 1
  • R. Geocadin
    • 2
  • C. Hall
    • 3
  • P. D. Le Roux
    • 4
  • S. Smirnakis
    • 1
  • C. A. C. Wijman
    • 5
  • O. O. Zaidat
    • 6
  1. 1.Division of Vascular Neurology and Neurocritical Care, Department of NeurologyBaylor College of MedicineHoustonUSA
  2. 2.Department of NeurologyJohns Hopkins UniversityBaltimoreUSA
  3. 3.Department of NeurologyUT Southwestern UniversityDallasUSA
  4. 4.Department of NeurosurgeryUniversity of PennsylvaniaPhiladelphiaUSA
  5. 5.Department of NeurologyStanford UniversityPalo AltoUSA
  6. 6.Department of NeurologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations